European Union Approves NOXAFIL(R) (Posaconazole) for Treatment of Invasive Fungal Infections Such As Coccidioidomycosis.
The European Commission (EC) has recently granted marketing approval to NOXAFILŽ (posaconazole) Oral Suspension for the treatment of group of fungal infections in adult patients -especially adult patients that are refractory to or who are intolerant of commonly used antifungal agents.
Read More